Given the continuous search for therapies against bacterial pathogens and to avoid the development of antibiotic resistance, interfering with the Agr QS system by using AIP analogues like 6-R may represent a potential candidate as a target to prevent some C. perfringens-mediated diseases, including gas gangrene. This evidence concerns the gene AIP and gas gangrene.